Trial Summary:

A clinical trial comparing the immunogenicity and safety of Japanese encephalitis vaccine administered by subcutaneous and intradermal routes.

Supported By:

NSW Ministry of Health and National Centre for Immunisation Research and Surveillance

Eligibility:

Inclusion:

• Aged 5 years or older at the time of consent
• Are in good health, as determined by the investigator.
• Able to comply with the study schedule

Exclusion:

• Meets health department recommendation for Japanese encephalitis vaccine to be given subcutaneously
• Previous Japanese encephalitis, dengue, or yellow fever vaccination, or are planning to have any of these vaccines during the study period
• History of dengue fever
• Contraindications to Japanese Encephalitis vaccination
• Are taking immunosuppressive medication or have medical conditions that impair the normal functioning of the immune system

Registration ID:

TBA

Participation:

Australia

Australian Lead Group:

Sydney Children’s Hospital Network

Status:

In development

Activation Date:

TBA

Chairs:

A/Prof Nicholas Wood

Contact:

jevid-2.study@sydney.edu.au